Michael Catelani insider trades: Anixa Biosciences (ANIX) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
7 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | ANIX | ↑ Buy | 5,500 | $2.84 | $16K | Direct | Sep 30, 2026 (0d) |
| Jan 15, 2025 | ANIX | ↑ Buy | 9,289 | $2.15 | $20K | Direct | Jan 15, 2025 (0d) |
| Jun 7, 2024 | ANIX | ↑ Buy | 6,250 | $2.40 | $15K | Direct | Jun 7, 2024 (0d) |
| Jul 20, 2023 | ANIX | ↑ Buy | 5,500 | $3.64 | $20K | Direct | Jul 21, 2023 (1d) |
| Apr 21, 2022 | ANIX | ↑ Buy | 5,500 | $2.66 | $15K | Direct | Apr 22, 2022 (1d) |
| Apr 20, 2022 | ANIX | ↑ Buy | 2,509 | $2.53 | $6K | Direct | Apr 21, 2022 (1d) |
| Sep 18, 2018 | ITUS | ↑ Buy | 2,250 | $4.45 | $10K | Direct | Sep 19, 2018 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other ANIX insiders
Open-market trades in the last 12 months
About Michael Catelani's insider trades
Michael Catelani is President, COO, & CFO at Anixa Biosciences (ANIX). Since Sep 18, 2018, Michael has reported 7 open-market purchases worth $102K and no sales on SEC Form 4. In the last 12 months: 1 buy ($16K).
Their filings also include grants and awards (17 filings), other transactions (8 filings), shares returned to the company (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ANIX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.